论文部分内容阅读
为确知海群生治疗罗阿丝虫病的疗效、治疗并发症及其预防措施,作者对100例16～65岁的男女性罗阿丝虫病患者进行了研究分析。 100例中76例经寄生虫学证实(57例微丝蚴血症阳性,19例在皮肤或结合膜找到成虫),24例根据临床症状和免疫电泳而诊断。全部病人均住院接受海群生治疗,每天剂量分2次服,剂量由小逐日增大。微丝蚴血症阳性者,第一天以3mg(基质)开始;微丝蚴血症阴性者,以12.5mg开始。以后每天剂量加倍,直至300～400mg/天(即6mg/kg),然后维持3周,整个疗程约4周。对于微丝蚴血症阳性者,一开始就同时给予抗组织胺药物,此药虽不能降低副反应的发生率,但可减轻其强度。若副反应明显
In order to confirm the efficacy of seaquotrous treatment of Loach’s disease and the treatment of complications and its preventive measures, the authors studied 100 cases of Loquat Disease in men and women aged 16 to 65 years. Seventy-six of the 100 cases were confirmed by the parasitemia (57 microfilariae positive, 19 found on the skin or the conjunctiva), and 24 were diagnosed on the basis of clinical signs and immunoelectrophoresis. All patients were hospitalized to receive sea life treatment, the daily dose of 2 times service, the dose increased day by day. Microfilaria positive, the first day to 3mg (matrix) began; microfilariaemia negative, beginning with 12.5mg. The daily dose is then doubled up to 300-400 mg / day (ie, 6 mg / kg) for 3 weeks followed by about 4 weeks of treatment. Microfilaria positive for those who, at the same time given antihistamine drugs, although the drug can not reduce the incidence of side effects, but can reduce the intensity. If the side effects are obvious